Feed Preview

Autoimmune Lymphoproliferative Syndrome

Autoimmune Lymphoproliferative Syndrome diagram by B1357M, Wikimedia
B1357M, Wikimedia

Autoimmune lymphoproliferative syndrome (ALPS) is a rare genetic disorder of abnormal lymphocyte survival caused by defective Fas mediated apoptosis. Discover the latest research on ALPS here.

Top 20 most recent papers
Clinical Nuclear Medicine

18F-FDG PET Imaging Features of Patients With Autoimmune Lymphoproliferative Syndrome

Clinical Nuclear MedicineNovember 7, 2019
Jorge A CarrasquilloV Koneti Rao
Advances in Experimental Medicine and Biology

Stimulatory and Inhibitory Co-signals in Autoimmunity

Advances in Experimental Medicine and BiologyNovember 24, 2019
Taku Okazaki, Il-Mi Okazaki
Nature Immunology

T cells instruct myeloid cells to produce inflammasome-independent IL-1β and cause autoimmunity

Nature ImmunologyDecember 19, 2019
Aakanksha JainChandrashekhar Pasare
Journal of Clinical Immunology

Autoimmune Lymphoproliferative Syndrome Presenting with Invasive Streptococcus pneumoniae Infection

Journal of Clinical ImmunologyMarch 8, 2020
Eric OksenhendlerAude Magérus
Frontiers in Pediatrics

Case Report: Exome Sequencing Reveals LRBA Deficiency in a Patient With End-Stage Renal Disease

Frontiers in PediatricsMarch 29, 2020
Christina TaylanBodo B Beck
The Journal of Clinical Investigation

Defective glycosylation and multisystem abnormalities characterize the primary immunodeficiency XMEN disease

The Journal of Clinical InvestigationNovember 13, 2019
Juan C RavellMichael J Lenardo
Multiple Sclerosis and Related Disorders

Switching from fingolimod to alemtuzumab in patients with highly active relapsing-remitting multiple sclerosis: Α case series

Multiple Sclerosis and Related DisordersNovember 22, 2019
Konstantinos NotasVasilios K Kimiskidis

Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis

NatureNovember 22, 2019
Melanie FritschHamid Kashkar

Increased mTOR activation in idiopathic multicentric Castleman disease

BloodMarch 25, 2020
Daniel J ArenasDavid C Fajgenbaum
Allergy, Asthma & Immunology Research

Flow Cytometry for the Diagnosis of Primary Immunodeficiency Diseases: A Single Center Experience

Allergy, Asthma & Immunology ResearchFebruary 5, 2020
Won Kyung KwonEun Suk Kang
The Science of the Total Environment

An inter-comparative evaluation of PKU-FUEL global SO2 emission inventory

The Science of the Total EnvironmentMarch 22, 2020
Jinmu LuoJianmin Ma
Frontiers in Immunology

Functions of Tfh Cells in Common Variable Immunodeficiency

Frontiers in ImmunologyFebruary 22, 2020
Corentin Le Saos-PatrinosDorothée Duluc
Case Reports in Immunology

Fatal Hypogammaglobulinemia 3 Years after Rituximab in a Patient with Immune Thrombocytopenia: An Underlying Genetic Predisposition?

Case Reports in ImmunologyJanuary 21, 2020
Jean-François ViallardFrédéric Rieux-Laucat
CNS Neuroscience & Therapeutics

Myeleterosis in an ALPS5 patient with primary immune dysregulation syndrome

CNS Neuroscience & TherapeuticsMarch 18, 2020
Hongyu LongHong Jiang
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology

Pediatric IgG4-related lymphadenopathy: A rare condition associated with autoimmunity and lymphoproliferative disorders

Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and ImmunologyNovember 27, 2019
Chiara MainardiMarta Pillon

See more papers from this feed

Related Feeds

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Addison Disease

Addison's disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Discover the latest research on Addison's disease here.

Adult-Onset Still's Disease

Adult-onset Still's disease (AOSD) is a form of Still's disease, a rare systemic autoinflammatory disease characterized by the classic triad of persistent high spiking fevers, joint pain, and a distinctive salmon-colored bumpy rash. Discover the latest research on AOSD here.

Anti-N-Methyl-D-Aspartate Receptor Encephalitis

Anti-N-Methyl-D-Aspartate (NMDA) receptor encephalitis is a form of of brain inflammation due to antibodies against NMDA receptors. Discover the latest research on anti-NMDA receptor encephalitis here.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Autoimmune Disease Therapy

In autoimmune diseases, the immune system responds and attacks self-antigens and damages or impairs the function of the tissues. The treatment for autoimmune diseases often involves immunosuppressive agents, but newer treatments are being investigated. Discover the latest research on autoimmune disease therapy here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

© 2020 Meta ULC. All rights reserved